SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett(National Institutes of Health), Darin K. Edwards(Moderna Therapeutics (United States)), Sarah R. Leist(University of North Carolina at Chapel Hill), Olubukola M. Abiona(National Institutes of Health), Seyhan Boyoglu-Barnum(National Institutes of Health), Rebecca A. Gillespie(National Institutes of Health), Sunny Himansu(Moderna Therapeutics (United States)), Alexandra Schäfer(University of North Carolina at Chapel Hill), Cynthia T. Ziwawo(National Institutes of Health), Anthony DiPiazza(National Institutes of Health), Kenneth H. Dinnon(University of North Carolina at Chapel Hill), Sayda M. Elbashir(Moderna Therapeutics (United States)), Christine A. Shaw(Moderna Therapeutics (United States)), Angela Woods(Moderna Therapeutics (United States)), Ethan J. Fritch(University of North Carolina at Chapel Hill), David R. Martinez(University of North Carolina at Chapel Hill), Kevin W. Bock(National Institutes of Health), Mahnaz Minai(National Institutes of Health), Bianca M. Nagata(National Institutes of Health), Geoffrey B. Hutchinson(National Institutes of Health), Kaichun Wu(Moderna Therapeutics (United States)), Carole Henry(Moderna Therapeutics (United States)), Kapil Bahl(Moderna Therapeutics (United States)), Dario Garcia-Dominguez(Moderna Therapeutics (United States)), LingZhi Ma(Moderna Therapeutics (United States)), Isabella Renzi(Moderna Therapeutics (United States)), Wing-Pui Kong(National Institutes of Health), Stephen D. Schmidt(National Institutes of Health), Lingshu Wang(National Institutes of Health), Yi Zhang(National Institutes of Health), Emily Phung(National Institutes of Health), Lauren A. Chang(National Institutes of Health), Rebecca J. Loomis(National Institutes of Health), Nedim Emil Altaras(Moderna Therapeutics (United States)), Elisabeth Narayanan(Moderna Therapeutics (United States)), Mihir Metkar(Moderna Therapeutics (United States)), Vladimir Presnyak(Moderna Therapeutics (United States)), Cuiping Liu(National Institutes of Health), Mark K. Louder(National Institutes of Health), Wei Shi(National Institutes of Health), Kwanyee Leung(National Institutes of Health), Eun Sung Yang(National Institutes of Health), Ande West(University of North Carolina at Chapel Hill), Kendra L. Gully(University of North Carolina at Chapel Hill), Laura J. Stevens(Vanderbilt University Medical Center), Nianshuang Wang(The University of Texas at Austin), Daniel Wrapp(The University of Texas at Austin), Nicole A. Doria‐Rose(National Institutes of Health), Guillaume Stewart-Jones(Moderna Therapeutics (United States)), Hamilton Bennett(Moderna Therapeutics (United States)), Gabriela Alvarado(National Institutes of Health), Martha Nason(National Institutes of Health), Tracy J. Ruckwardt(National Institutes of Health), Jason S. McLellan(The University of Texas at Austin), Mark R. Denison(Vanderbilt University Medical Center), James D. Chappell(Vanderbilt University Medical Center), Ian N. Moore(National Institutes of Health), Kaitlyn M. Morabito(National Institutes of Health), John R. Mascola(National Institutes of Health), Ralph S. Baric(University of North Carolina at Chapel Hill), Andrea Carfı́(Moderna Therapeutics (United States)), Barney S. Graham(National Institutes of Health)
Cited by 1,643Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis